Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology
Soft Tissue Sarcoma Clinical Trials
A listing of Soft Tissue Sarcoma medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 Last
Arizona
Mayo Arizona
Scottsdale Arizona 85259
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Arizona Cancer Center
Tucson Arizona 85719
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
California
City of Hope National Medical Center
Duarte California 91010
Patients are needed to participate in a clinical research study of I-131-CLR1404 to evaluate Cancer
USC-Norris Comprehensive Cancer Center
Los Angeles California 90033
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
University of California, Los Angeles
Los Angeles California 90095-6901
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Sarcoma Oncology Center
Santa Monica California 90403
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Stanford University School of Medicine
Stanford California 94305
A clinical trial to evaluate treatments using Paclitaxel in combination with Bevacizumab for patients with Hemangiosarcoma or Soft Tissue Sarcoma
View More »
Stanford Comprehensive Cancer Center
Stanford California 94305
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
District of Columbia
Washington Cancer Institute
Washington District of Columbia 20010
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Georgetown University Hospital
Washington District of Columbia 20007
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Georgetown University Hospital
Washington District of Columbia 20007-2113
Patients are needed to participate in a clinical research study of I-131-CLR1404 to evaluate Cancer
Florida
South Florida Center for Gynecologic Oncology
Boca Raton Florida 33487
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Mayo Clinic-Florida-Cancer Clinical Studies Unit
Jacksonville Florida 32224
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
H.Lee Moffitt Cancer Center and Research Institute
Tampa Florida 33612
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Georgia
Winship Cancer Institute of Emory University, Midtown Campus
Atlanta Georgia 30322
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Georgia Cancer Specialists
Sandy Springs Georgia 30342
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Idaho
Kootenai Health - Kootenai Cancer Center
Coeur d'Alene Idaho 83814
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Illinois
Northwestern University
Chicago Illinois 60611
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Rush University Medical Center
Chicago Illinois 60612
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Oncology Specialists
Park Ridge Illinois 60068
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Indiana
Indiana University Simon Cancer Center
Indianapolis Indiana 46202
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Iowa
University of Iowa Hospitals and Clinics
Iowa City Iowa 52242
A clinical trial to evaluate treatments using Bevacizumab, Gemcitabine, docetaxel and valproic acid for patients
University of Iowa Health Care - University of Iowa Hospital
Iowa City Iowa 52242
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Maryland
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Baltimore Maryland 21287
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Massachusetts
Dana Farber Cancer Institute Center for Sarcoma and Bone Oncology
Boston Massachusetts 02215
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Michigan
University of Michigan Cancer Center
Ann Arbor Michigan 48109
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Minnesota
Mayo Rochester
Rochester Minnesota 55905
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Missouri
Washington University School of Medicine
St. Louis Missouri 63110
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
New York
Montefiore
Bronx New York 10461
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Roswell Park Cancer Institute
Buffalo New York 14263
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Memorial Sloan-Kettering Cancer Center
New York New York 10031
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Columbia University Medical Center
New York New York 10032
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
North Carolina
Carolinas Hematology-oncology Associates-Blumenthal Cancer Center
Charlotte North Carolina 28203
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Duke University Medical Center
Durham North Carolina 27710
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Wake Forest University Baptist Medical Center
Winston-Salem North Carolina 27157
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Ohio
University Hospitals Seidman Cancer Center
Cleveland Ohio 44106
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Cleveland Clinic Foundation
Cleveland Ohio 44195
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Oregon
Oregon Health and Science University
Portland Oregon 97239
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Pennsylvania
Fox Chase Cancer Center
Philadelphia Pennsylvania 19111
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Pennsylvania Oncology Hematology Associates
Philadelphia Pennsylvania 19106
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
University of Pittsburg Medical Center
Pittsburgh Pennsylvania 15232
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
South Carolina
MUSC - Hollings Cancer Center
Charleston South Carolina 29425
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Tennessee
Vanderbilt-Ingram Cancer Center
Nashville Tennessee 37232
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Texas
MD Anderson Sarcoma Center
Houston Texas 77030
A clinical trial to evaluate treatments using Paclitaxel in combination with Bevacizumab for patients with Hemangiosarcoma or Soft Tissue Sarcoma
Vermont
University of Vermont
Burlington Vermont 05405
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Fletcher Allen Health Care
Burlington Vermont 05401
A Phase 1/Phase 2 clinical study for patients with Operable Soft Tissue Sarcoma
Virginia
Virginia Commonwealth Universtiy-Massey Cancer Center
Richmond Virginia 23298
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Washington
University of Washington Cancer Center
Seattle Washington 98109
A clinical trial to evaluate treatments using TH-302 in Combination with Doxorubicin and Doxorubicin for patients with Soft Tissue Sarcoma
Wisconsin
University of Wisconsin Hospital and Clinics
Madison Wisconsin 53792
Patients are needed to participate in a clinical research study of I-131-CLR1404 to evaluate Cancer
First 1 2 3 Last